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Comparative study of Candida albicans colony count means in the 
saliva of healthy subjects in terms of ABO blood group antigens 
 
 




Introduction: Candida albicans is the most prevalent opportunistic fungus in the oral cavity. To 
date, the association of various factors with the incidence of candidiasis has been evaluated. Some 
studies have yielded conflicting results about the association between ABO blood group antigens 
and candidiasis. The aim of this study was to evaluate the relationship between the mean colony 
counts of C. albicans in the saliva of healthy subjects and their association with ABO blood 
antigens. 
Materials and Methods: Three hundreds healthy subjects (100 with blood group A, 100 with blood 
group B and 100 with blood group O) were included in this cross-sectional/analytical study. The 
unstimulated salivary samples of all the participants were collected by spiting, which were cultured 
to determine the colony counts in each subject’s saliva. Data were analyzed by SPSS 16 by Kruskal-
Wallis test and Pearson’s correlation coefficient. 
Results: The subjects included 156 males and 144 females, with a mean age of 27.52 years. The 
mean colony counts of C. albicans in the O, A and B blood groups were 26.4, 19.84 and 21.23, 
respectively. The results did not show significant differences between the three blood groups in the 
mean colony counts of C. albicans. 
Conclusion: Under the limitations of this study there was no relationship between colony counts 
and blood types. Further studies are recommended to confirm the effect of ABO blood group 
(especially blood group O) on susceptibility to candidiasis. 
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